CLINICAL_TRIALS trial_result · 2025-09-23

Clinical Trial Update: A First-in-human Trial of GEN3017 in Hodgkin Lymphoma and Non-Hodgkin Lymphoma [Phase 1, Phase 2]

A first-in-human phase 1/2 trial of GEN3017 in classical Hodgkin lymphoma and non-Hodgkin lymphoma was terminated, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Genmab | Conditions: Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-09-23